Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: A cross-sectional study

Cancer Epidemiology

Volumn 36, Issue 5, 2012, Pages

  Sánchez Lander, Jorge ^a   Cortiñas, Paula ^b   Loureiro, Carmen Luisa ^c   Pujol, Flor Helene ^c   Medina, Francisco ^a   Capote Negrín, Luis ^d   Bianchi, Gino ^e   García Barriola, Victoria ^e   Ruiz Benni, Angela ^a   Avilán Rovira, José ^e   Acosta, Humberto ^f  

^a Thoracic Oncology Section   (Venezuela)

^b Gynaecology Unit   (Venezuela)

^c INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^d Venezuelan Ministry of Health   (Venezuela)

^e UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^f Hospital Vargas de Caracas   (Venezuela)

Author keywords

Cervical cancer; Cervical lesion; Cervix; High risk human papillomavirus; Prevalence; Venezuela

Indexed keywords

PARAFFIN;

ADULT; AGED; ARTICLE; CANCER INVASION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VENEZUELA; WART VIRUS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CAUSALITY; CAUSE OF DEATH; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INCIDENCE; MIDDLE AGED; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VENEZUELA; YOUNG ADULT;

EID: 84865860934     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.04.005     Document Type: Article

References (16)

1. Ministerio del Poder Popular para la Salud. Gobierno Bolivariano de Venezuela. Anuario de Mortalidad 2008. Available at: http://www.mpps.gob.ve/images/stories%20/anuario_2008.zip.
2. Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 2008, 110(3 Suppl. 2):S4-S7.
3. Correnti M., Medina F., Cavazza M.E., Rennola A., ávila M., Fernándes A. Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women. Gynecol Oncol 2011, 121(3):527-531.
4. Parkin D.M., Almonte M., Bruni L., Clifford G., Curado M.P., Piñeros M. Burden and trends of type-specific Human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine 2008, 26(Suppl. 11):L1-L15.
5. International Agency for Research on Cancer. Globocan 2008. World Health Organization. Available at [September 2011]. http://www.globocan.iarc.fr/.
6. World Health Organization. WHO/ICO information centre on HPV and Cervical Cancer (HPV information Centre) human papillomavirus and related Cancers in Americas. Summary Report 2010. Available at: [September 2011]. http://www.who.int/hpvcentre.
7. Stanley M. Prevention strategies against the human papillomavirus: the effectiveness of vaccination. Gynecol Oncol 2007, 107(2 Suppl. 1):S19-S23.
8. Instituto Nacional de Estadística. Censo 2001. [September 2011]. Available at http://www.ine.gov.ve/.
9. Castle P.E., Schiffman M., Wheeler C.M., Solomon D. Evidence for frequent regresion of cervical intraepithelial neoplasia grade 2. Obstet Gynecol 2009, 113:18-25.
10. Castle P.E., Stoler M.H., Solomon D., Shiffman M., for the ALTS Group The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology reviewed diagnoses. Am J Clin Pathol 2007, 127:805-815.
11. Clifford G.M., Smith J.S., Plummer M., Muñoz N., Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88:63-73.
12. de Sanjosé S., Quint W.G.V., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras B., et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010, 11(11):1048-1056.
13. Wheeler C.M., Hunt W.C., Joste N.E., Key C.R., Quint W.G., Castle P.E. Human papillomavirus genotype distribution: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 2009, 101(7):475-487.
14. Sjoeborg K.D., Tropé A., Lie A.K., Jonassen C.M., Steinbakk M., Hansen M., et al. HPV genotype distribution according to severity of cervical neoplasia. Gynecol Oncol 2010, 118:29-34.
15. Herrero R. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. J Infect Dis 2009, 199(7):919-922.
16. Muñoz N., Kjaer S., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Wheeler C.M., et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 2010, 102:325-339.